Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Streptomyces lividans IAF18, obtained by homologous cloning, is capable of over-producing XlnA. To investigate the possibility of the expression of foreign genes, various coding regions of the xylanase A gene (xlnA) were analysed. Expression/secretion vectors were constructed containing the regulatory elements of xlnA with the coding region of the leader peptide with or without the truncated structural gene encoding the first 310 amino acids of the XlnA. The genes coding for the Escherichia coli
beta-glucuronidase
and subunit 1 of the
Bordetella
pertussis toxin (S1) were used and their expression analysed. S. lividans transformants where the
beta-glucuronidase
gene was fused with the leader sequence produced up to 30 mg
beta-glucuronidase
/culture filtrate whereas only fused XlnA/S1 was detected and its yield was estimated to be 1 mg/1. The disappearance of the B. pertussis toxin S1 and
beta-glucuronidase
from the culture medium was due to the concomitant appearence of secreted proteases from S. lividans.
...
PMID:Expression and secretion of beta-glucuronidase and Pertussis toxin S1 by Streptomyces lividans. 876